OpenNashPodcasts

Topic

Dave Ricks

Dave Ricks is the CEO of Eli Lilly, and this page collects what he said on podcasts including Cheeky Pint and Fortune's Leadership Next, covering GLP-1 drugs, why new medicines take so long to develop, and the business of pharma. Ricks said he is the 11th CEO in the company's roughly 150-year history.

Ricks told Leadership Next that drug development across the industry takes 13 or 14 years and that Lilly has cut its own times roughly in half. He also said tirzepatide reduces body weight by about 20 percent on average, and that Americans pay about 3 percent of hospital costs out of pocket but about 20 percent of pharmacy costs.

17 facts from 2 episodes, in date order. These are what speakers said on the shows, each linked to the moment it was said. They aren't independently verified.

Undated

Dave Ricks says drug development across the pharmaceutical industry takes 13 or 14 years in total, and most Eli Lilly scientists never work on a successful drug in their careers.

“In total, in the industry, that takes 13 or 14 years. Most of our scientists, the thousands of people who work here, actually never work on something that's successful in their whole career.”

Dave Ricks · Eli Lilly CEO On Why Making New Drugs Is Hard, Takes So Long, And Costs So Much, 0:03:19

Episodes